Press

After he was not accepted into the University of Hong Kong, plan B for W.K. Alfred Yung, MD, was to leave his country and immigrate to the United States to attend the University of Minnesota in Minneapolis—a move he considers…

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment…

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview…

FOR IMMEDIATE RELEASE: May 25, 2021 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of…

5 Questions With…” is a weekly BioBuzz series where interesting people share a little about themselves, their work and maybe something completely unrelated. This week the series features Dr. Sujuan Ba, president and chief executive officer of the National Foundation…

FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of…

PHILADELPHIA – The American Association for Cancer Research (AACR) announced today that Daniel D. Von Hoff, MD, FACP, FASCO, FAACR, will receive the inaugural AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research.…